Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

KONE hosts a Capital Markets Day today, on September 25, 2018, in Helsinki

KONE Corporation, press release, September 25, 2018 at 07.00 a.m. EEST KONE hosts a Capital Markets Day today, on September 25, 2018, in Helsinki KONE organizes a Capital Markets Day for institutional investors and analysts in Helsinki today, on September 25, 2018. The aim of the Capital Markets Day is to provide an update on KONE's progress in its strategy execution and the key focus areas going forward. Both strategic and financial targets remain unchanged. President and CEO Henrik Ehrnrooth: "We are making good progress towards our strategic targets with our Winning with

Mekonomen announces the terms of its rights issue

Mekonomen AB (publ) (”Mekonomen” or the ”Company”) announced on 24 August 2018 that the Board of Directors had resolved, subject to approval at the extraordinary general meeting on 26 September 2018, to launch a rights issue with preferential rights for existing shareholders. Mekonomen’s Board of Directors today announces the terms of the rights issue through this press release. The rights issue in brief: · Shareholders in Mekonomen have preferential rights to subscribe for four (4) new shares per seven (7) existing shares, indicating a subscription ratio of 4:7. · The

Asarina Pharma: sharp rise on first day of trading on Nasdaq First North

After 40 years’ of research developing its breakthrough PMDD treatment Sepranolone, Asarina Pharma hit the ground running on Monday 24 September as it launched on Nasdaq First North in Stockholm. With major institutions getting behind the research—how did the successful market launch feel for the scientific and business team at Asarina Pharma?WHAT DOES TODAY MEAN TO YOU? CEO, Peter Nordkild: “We’ve come a long way–yet in many ways this is just another beginning. Now it’s time to deliver. A successful flotation increases our responsibility to deliver the results from our Phase IIB study

Summary from the Extraordinary General Meeting of 2018 of Resurs Bank

Resurs Bank Aktiebolag has resolved to distribute a dividend to the parent company Resurs Holding AB (publ) of SEK 660 per share (in total SEK 330,000,000). The dividend is a result of the company, as from autumn 2017, has half-yearly dividends. The payment shall be executed on 1 October 2018. For additional information:Peter Rosén, CFO & Head of IR, peter.rosen@resurs.se  +46 736 56 49 34Sofie Tarring, IR-Officer, sofie.tarring@resurs.se +46 736 44 33 95  About Resurs BankResurs was founded in 1977 and is one of the fastest-growing niche banks in the Nordic region. During the

Helsinki wins European Capital of Smart Tourism 2019 competition

Photo: Aleksi Poutanen Helsinki has taken first place in the European Commission’s new European Capital of Smart Tourism 2019 competition. The title for 2019 was awarded to two cities: Helsinki and Lyon. The final selection took place on 24 September 2018 in Brussels, where Pia Pakarinen, Deputy Mayor of Helsinki, and Laura Aalto, CEO of Helsinki Marketing, presented Helsinki’s winning entry under the theme “Helsinki – taking smart to new heights”. ”Helsinki as a city is committed to promoting sustainable development and is showing the way in this regard also within the

Share-based incentive scheme

The share-based incentive scheme resolved by the 2018 Annual General Meeting, comprising about 25 members of management and a maximum of 300,000 call options on repurchased class B shares, has been fully subscribed. The call options are transferred at a price of SEK 13.30 per call option, equivalent to the market value according to an external independent valuation, applying the Black & Scholes model. The redemption price of the call options amounts to SEK 232.90, equivalent to 120 percent of the volume-weighted average of market prices for the shares during the period from 31 August to

Hoist Finance AB (publ) issues EUR250 million senior notes and announces final results of tender offer

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.Hoist Finance AB (publ) (Baa3/stable) (the “Company”), today announces issuance of new EUR 250m 4.5-year senior unsecured notes at m/s+250bp under its EMTN-programme (ISIN XS1884813293). This transaction followed the successful completion of European investor meetings. Settlement date is 28 September 2018. The Company also announces the final results of its invitation to holders to tender their

Ossur Hf : Transactions in relation to share buyback program

Announcement no. 56/2018 24 September 2018  Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the share buyback program is to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The program will end no later than 28 February 2019. The Company may purchase up to 5,000,000 shares under the program, corresponding to 1.1% of the current share

ContextVision tar stora kliv mot en ny marknad - appearance in online magazine Investeringstipset

Stockholm, September 24th, 2018 - An update on ContextVision has been published in the Swedish online magazine Investeringstipset (in Swedish only). Please find a link here.  For further information, please contact ContextVision's CEO, Anita Tollstadius, at +46 70 337 30 26 or visit www.contextvision.com. ### About ContextVision ContextVision is a medical technology software company that specializes in image analysis and artificial intelligence. ContextVision is the global market leader within image

CEO Melvin Samsom has taken the decision to leave Karolinska University Hospital during spring 2019

Melvin Samsom has decided to leave his position as CEO of Karolinska University Hospital but will continue in his position until spring 2019. - I have been at Karolinska University Hospital for four years and during that time had the privilege of leading the major changes we are implementing together with our fantastic employees. We have now reached a point where the hospital needs a new form of leadership moving into the next phase. - I want to ensure the best possible handover conditions for the next CEO and have therefore already today met with the Director of the Stockholm County

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 24.09.2018

Fiskars Corporation NOTIFICATION 24.09.2018 at 18:30 EESTFISKARS CORPORATION: ACQUISITION OF OWN SHARES 24.09.2018 Date 24.09.2018  Exchange transaction Buy  Share class FSKRS  Amount  1 000  Average price/share 18.0898 EURHighest price/share 18.1400 EURLowest price/share 18.0200 EURTotal price 18,089.80 EUR      The shares held by Fiskars Corporation on 24.09.2018:   FSKRS  272,305   On behalf of Fiskars CorporationSkandinaviska

EAB Group Plc: SHARE REPURCHASE 24.9.2018

EAB GROUP Plc                            ANNOUNCEMENT           24.9.2018 SHARE REPURCHASE 24.9.2018 In the Helsinki Stock Exchange Trade date 24.9.2018Bourse trade BUYShare EABGBAmount 500 sharesTotal cost 1 770,00 EURAverage price/ share 3,5400 EUR EAB Group Plc now holds a total of 21.915 sharesincluding the shares repurchased on 24.9.2018. On behalf of EAB Group Plc. Nordea Bank AB (publ), Finnish Branch Janne Sarvikivi         Ilari IsomäkiFurther information:EAB Group Plc

EMA approves AZ's Imfinzi for Stage III NSCLC

24 September 2018 16:10 BST European Commission approves Imfinzi for locally-advanced, unresectable NSCLC Phase III PACIFIC trial demonstrated compelling overall survivalbenefit and progression-free survival of more than 11 months Imfinzi is the only immunotherapy medicine approved forthe treatment of locally-advanced, unresectable NSCLC   AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the European Commission has granted marketing authorisation for Imfinzi (durvalumab) as monotherapy for the treatment of locally-

Deja vu in LutherCountry:

What Martin Luther would recognize todayReformation Day on October 31st is a good time to think about “then” and “now”. In the region, where Luther lived and worked, for example, what would look familiar to the Great Reformer?  Astonishingly, the answer is: “Lots!” LutherCountry , the German federal states of Thuringia and Saxony-Anhalt, still has much that Luther would recognize. And it is easy to find, from medieval houses along Germany’s Half-Timbered Houses Route to cultural treasures, such as castles and gardens. But this part of Germany offers more

Publication of a Prospectus

Regulatory Announcement Royal Bank of CanadaSeptember 24, 2018 Publication of Prospectus Not for release, publication or distribution, directly or indirectly, in or into the United States. The following prospectus has been approved by the UK Listing Authority and, along with the documents incorporated by reference therein, is available for viewing: Notes Base Prospectus dated September 24, 2018 relating to the Programme for the Issuance of Securities of Royal Bank of Canada which was approved by the UK Listing Authority on September 24, 2018. The Prospectus, together

DDM raises EUR 12 million of senior secured bonds and lower its cost of funding

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, THE REPUBLIC OF CYPRUS, HONG KONG, THE REPUBLIC OF ITALY, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA, THE UNITED KINGDOM, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES.DDM Holding AG (First North: DDM) reaches agreement to refinance its subsidiary DDM Finance AB's EUR 10 million senior secured bonds maturing November 6, 2018 by way of issuing EUR 12 million

Changes to interest rates on SpareBank 1 Nord-Norge mortgages

SpareBank 1 Nord-Norge has decided to raise its mortgage rates by 0.25 percentage points.– The money market rates have increased over the course of 2018. This rate increase is a consequence of that, says Rolf Eigil Bygdnes, CFO at SpareBank 1 Nord-Norge.  Bygdnes believes that the rate increase is expected:  – It’s been a long time since the Governor of the Central Bank of Norway suggested that a change would arrive this autumn. We have been experiencing historically low interest rates for many years. I think most people were prepared for an increase.  Always competitive

Scanian of the Year Andreas Granqvist gets his portrait at Malmö Airport

The Scanian of the Year 2018, named by the readers of the Swedish daily Kvällsposten, is the favourite of the whole of Sweden – “Granen”, Andreas Granqvist, who plays football with Helsingborgs IF  and has been captain of the Swedish national men’s team since 2016. Today he was on hand at Malmö Airport along with airport director Peter Weinhandl, who unveiled the football player’s portrait, which will greet all visitors to Scania in the Welcome to My Hometown gallery. The honour “Scanian of the Year” has been awarded since 1967. For many

Nomination Committee in Intrum

At Intrum AB's Annual General Meeting on 27 April 2018, it was resolved that the Chairman of the Board of Directors should form a Nomination Committee by convening representatives for the five largest shareholders of the company, based on the number of votes known to be held at the end of August.Following contacts with the company's shareholders, the following members have been appointed: · Robert Furuhjelm, appointed by Cidron 1748 Sarl · Patrick Lapveteläinen, appointed by Sampo plc · Carl Cederschiöld, appointed by Handelsbanken Fonder · Mats Gustafsson, appointed by

Ponsse’s President and CEO Juho Nummela named businessperson of the year

Ponsse Plc’s President and CEO Juho Nummela was named businessperson of the year (Vuoden Liikemies) in an annual event held by Suomen Liikemiesyhdistys in cooperation with Kauppalehti and Aalto University.  This marked the first time when the second person from a single company has received the recognition. Ponsse’s founder Einari Vidgrén was presented with the recognition in 1997. The choice for the businessperson of the year (Vuoden Liikemies) was published on Monday evening in an event held in Helsinki. The criteria for the recognition mentioned that Juho Nummela combines the

Flywire and Allianz Global Assistance Announce Partnership to Manage and Protect College Students’ Tuition Payments

Partnership provides colleges a solution to protect families and help students reach college attainmentFlywire  and Allianz Global Assistance today announced a new partnership that mutually benefits higher education institutions and their students by managing and protecting college students’ tuition payments. The new partnership combines Flywire’s turnkey, end-to-end solution for managing tuition receivables, powered by OnPlanU, with the ability for families to purchase the GradGuard Tuition Protection Plan* from Allianz Global Assistance, as an extension

Ribbskottet AB increases its stake in Xspray Pharma

STOCKHOLM - September 24, 2018. Xspray Pharma (Nasdaq First North: XSPRAY) (“Xspray”) has received information that Ribbskottet AB has purchased a total of 223,000 shares in the company from Recipharm Venture Fund AB. The transfer took place outside the stock exchange. Ribbskottet’s holding in Xspray now amounts to 10 percent of the number of shares and votes, which means that Ribbskottet becomes Xspray’s second-largest shareholder. The sale was made at the current stock price.Ribbskottet AB has since Xspray’s introduction on First North in September 2017 been one of its ten largest owners.

Vestas - Transactions in connection with share buy-back programme, week 38 2018

Vestas Wind Systems A/S, Aarhus, 24 September 2018Company announcement No. 36/2018  Transactions in connection with share buy-back programme, week 38 2018On 15 August 2018, Vestas initiated a share buy-back programme, ref. Company announcement No. 28/2018 . The programme is implemented in accordance with Regulation No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour”

Ribbskottet AB increases its stake in Xspray Pharma

STOCKHOLM - September 24, 2018. Xspray Pharma (Nasdaq First North: XSPRAY) (“Xspray”) has received information that Ribbskottet AB has purchased a total of 223,000 shares in the company from Recipharm Venture Fund AB. The transfer took place outside the stock exchange. Ribbskottet’s holding in Xspray now amounts to 10 percent of the number of shares and votes, which means that Ribbskottet becomes Xspray’s second-largest shareholder. The sale was made at the current stock price.Ribbskottet AB has since Xspray’s introduction on First North in September 2017 been one of its ten largest owners.

There are no items matching the current filter
There are no more items matching the current filter
Back to top